As such, identification of these patients as high risk early in their disease course and appropriate treatment with renin–angiotensin–aldosterone system inhibitors, sodium–glucose co-transporter-2 inhibitors and finerenone could prevent a lifetime risk of kidney failure. The gene discussed is REN; the disease is kidney failure.